Matrix Metalloproteinase 14 in Corneal Neovascularization

Area of Science:

• Ophthalmology
• Molecular Biology
• Biochemistry

Background:

• Corneal neovascularization (CoNV) impairs vision by disrupting the cornea's avascularity.
• Matrix metalloproteinases (MMPs), particularly membrane-bound MMP-14, are key regulators of CoNV.
• Current CoNV therapies show limited efficacy.

Purpose of the Study:

• To elucidate the multifaceted role of MMP-14 in corneal neovascularization.
• To explore MMP-14 as a therapeutic target for CoNV.

Main Methods:

• Review of literature on MMP-14 function in corneal angiogenesis.
• Analysis of MMP-14's pro-angiogenic and anti-angiogenic mechanisms.
• Evaluation of existing and novel therapeutic strategies targeting MMP-14.

Main Results:

• MMP-14 promotes CoNV via matrix degradation, growth factor signaling modulation, and endothelial cell migration.
• MMP-14 also exhibits anti-angiogenic potential through fragment generation (e.g., neostatin-14).
• MMP-14's involvement in corneal wound healing and lymphangiogenesis highlights its therapeutic relevance.

Conclusions:

• MMP-14 is a critical mediator in CoNV, with both pro- and anti-angiogenic functions.
• Targeting MMP-14 presents a promising avenue for novel CoNV therapies.
• Further understanding of MMP-14 regulation is essential for effective therapeutic modulation of angiogenesis in the cornea.